Furanomycin | 15379-21-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: Furanomycin
• 英文别名: amino-(5-methyl-2,5-dihydro-furan-2-yl)-acetic acid；2-amino-2-(5-methyl-2,5-dihydro-2-furyl)acetic acid；2-amino-2-(5-methyl-2,5-dihydro-furan-2-yl)acetic acid；2-azaniumyl-2-(5-methyl-2,5-dihydrofuran-2-yl)acetate
• CAS: 15379-21-2
• 化学式: C₇H₁₁NO₃
• 分子量: 157.169
• InChiKey: PNOKUGWGMLEAPE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -2.8
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  72.6
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• Inhibitors of hepatitis C virus NS3 protease
  申请人：——

  公开号：US20020065248A1

  公开（公告）日：2002-05-30

  The present invention relates to compounds of Formula (I): 1 wherein A 1 is methylene, ethylene or propylene group and A 2 is N or CR 5 , or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HCV NS3 protease, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.

  本发明涉及化合物的结构公式（I）：其中A1为亚甲基、乙烯基或丙烯基，A2为N或CR5，或其立体异构体形式、立体异构体混合物或药用盐形式，用作HCV NS3蛋白酶的抑制剂，以及包含相同化合物的药物组合物和诊断试剂盒，以及用于治疗病毒感染或作为测定标准或试剂的方法。
• [EN] HETEROCYCLIC SULFONAMIDES AS INHIBITORS OF TRANSFER RNA SYNTHETASE FOR USE AS ANTIBACTERIAL AGENTS<br/>[FR] SULFAMIDES HÉTÉROCYCLIQUES SERVANT D'INHIBITEURS DE SYNTHÉTASE D'ARN DE TRANSFERT, DESTINÉS À ÊTRE UTILISÉS EN TANT QU'AGENTS ANTIBACTÉRIENS
  申请人：RANBAXY LAB LTD

  公开号：WO2012014109A1

  公开（公告）日：2012-02-02

  The present invention provides aromatic sulphonamides as tRNA synthetase inhibitors and process for their synthesis, pharmaceutical composition and method for treatment. Compounds disclosed can be used as antibacterial agents for the treatment or prevention of conditions caused by or contributed by aerobic and anaerobic Gram-positive pathogens, more particularly against bacterium, for example Staphylococcus, Enterococci and Streptococci. Compounds disclosed are used in particular for the treatment of skin and soft tissue infection, Formula (I).

  本发明提供了芳香磺胺类化合物作为tRNA合成酶抑制剂，以及它们的合成方法、药物组合物和治疗方法。所披露的化合物可用作抗菌剂，用于治疗或预防由厌氧和厌氧革兰氏阳性病原体引起或促成的疾病，特别是对抗细菌，例如葡萄球菌、肠球菌和链球菌。所披露的化合物特别用于治疗皮肤和软组织感染，化学式(I)。
• Antibacterial methods and compositions
  申请人：——

  公开号：US20040224981A1

  公开（公告）日：2004-11-11

  Disclosed is a pharmaceutical composition comprising an aminoacyl tRNA synthetase inhibitor and another antibacterial agent, including another aminoacyl tRNA synthetase inhibitor.

  本发明揭示了一种药物组合物，包括一种氨酰tRNA合成酶抑制剂和另一种抗菌剂，其中包括另一种氨酰tRNA合成酶抑制剂。
• Peptide inhibitors of hepatitis C virus NS3 protein
  申请人：——

  公开号：US20020177725A1

  公开（公告）日：2002-11-28

  This invention relates to a novel class of peptides having the Formula (I): 1 Which are useful as serine protease inhibitors, and more particularly as Hepatitis C virus(HCV) NS3 protease inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same in the treatment of HCV infection.

  本发明涉及一类新型肽的公式(I)：1，其作为丝氨酸蛋白酶抑制剂具有用途，更具体地作为丙型肝炎病毒（HCV）NS3蛋白酶抑制剂。本发明还涉及包含这些化合物的制药组合物以及使用它们治疗HCV感染的方法。
• Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues
  申请人：——

  公开号：US20020042097A1

  公开（公告）日：2002-04-11

  Methods for producing modified polypeptides containing amino acid analogues are disclosed. The invention further provides purified dihydrofolate reductase polypeptides, produced by the methods of the invention, in which the methionine residues have been replaced with homoallyglycine, homoproparglycine, norvaline, norleucine, cis-crotylglycine, trans-crotylglycine, 2-aminoheptanoic acid, 2-butynylglycine and allylglycine.

  本发明揭示了制备含有氨基酸类似物的修饰多肽的方法。本发明进一步提供了通过本发明的方法生产的纯化的二氢叶酸还原酶多肽，其中甲硫氨酸残基已被替换为同烯基甘氨酸、同丙炔基甘氨酸、正异戊氨酸、正异癸氨酸、顺-十四烷基甘氨酸、反-十四烷基甘氨酸、2-氨基庚酸、2-丁炔基甘氨酸和烯丙基甘氨酸。